← Leaderboards
Michael J Volles
Harvard Medical School
$165,894
Attributed
$165,894
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $57.7K · FY2008–10$100K$75K$50K$25K$0
'08
'09
'10
Funding mix
By agency
NIH$165,894 · 1
By mechanism
F32$165,894 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Vicki Rosen$14,120,707
- Wei-Dong Yao$11,300,934
- Christophe O Benoist$53,813,482
- Mohammed S Razzaque$1,451,513
- Natasha O'Brown$945,079
Others in their field
Top investigators on “Established Cell Line”
- Dennis R. Burton · Scripps Research Institute$199,946,411
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$112,015,410
- David Heimbrook · Leidos Biomedical Research, Inc.$110,140,839
- Kc Kent Lloyd · University Of California At Davis$68,551,303
Research focus
Established Cell LineAminoglycosidesAntibiotic G 418Blood CellsBaseBone Marrow PurgingBone Marrow TransplantationBloodCell FractionCell GrowthCellsBone MarrowChromosomesCleaved CellCongenicDesignDisadvantagedCancer EtiologyElectroporationEmbryoEndonucleaseEngineeringEnzymesEvent
Grant awards (3)
Gene correction in hematopoitic stem cells using a retargetable meganuclease$57,686
F32 · FY2010 · GM · contact PI
Gene correction in hematopoitic stem cells using a retargetable meganuclease$55,310
F32 · FY2009 · GM · contact PI
Gene correction in hematopoitic stem cells using a retargetable meganuclease$52,898
F32 · FY2008 · GM · contact PI